Novartis and Sangamo Therapeutics plan to pursue potential treatments for neurodevelopmental diseases.

Novartis supports promising young scientists who want to improve their chances to attain advanced science degrees.

Novartis researcher Joana Silva had a life-changing experience with a mentor.

The molecule restores the activity of neurons and neural circuits in a model of the disease.

Great progress has been made against malaria, but signs of resistance are becoming a rising concern

Accelerating Research to Get Answers Faster

Oncology Regulatory Affairs Leader Hannah Mosca describes her lifelong interest in science and math, and what it’s like to work at Novartis